Now we look at the introduction: in Ukraine, a new drug of substitution therapy is being promoted.

The drug can be used in the pharmaceutical form for injections to avenge the intoxication of buprenorphine with prolonged release. Now the patient is guilty of more than one injection per month for the replacement of a given tablet.

Experts at the Center for Public Health indicate that the drug may be of benefit both for stable patients and for those who find it difficult to manage the daily intake of drugs.

Confirming this, de Buvidal was compared with sublingual tablets against buprenorphine and naloxone, the blocking effect of opioids, and zocrema in case of overdose.

The results showed that patients who were taking Buvidal were more likely to be treated with drugs compared to patients who were taking pills.

Lіkar to the site of OST in Nіmechchinі appointed that among її patients only 3 otrimuyutnya. The reason for this is that no matter how insurance covers such therapy: the cost of one monthly dosing becomes close to €200 euros. In Ukraine, the purpose of likuvannya is cost-free.

In 2023, it is planned to promote the promotion of a new drug from the promotion of a new drug in 11 mortgages in 10 regions.

Buvidal has already been taken from Vinnitsa, Volynsk, Lviv, Rivne, Ivano-Frankivsk, Sumy and Poltava regions. Until the end of the fierce, the drug will also be delivered to Zakarpattia, Zaporizhia and Dnipropetrovsk region. In these regions, lay the foundation for the protection of health.

https://newsyou. info/ Keywords:.